IL22 and autoimmune thrombocytopenic purpura: Cao et al(22) observed that plasma levels of IL-22 were significantly increased in patients with active ITP, and high-dose dexamethasone administration reduced IL-22 production and corrected the imbalance between Th1 and Th22 subsets.